The advertisement promotes ADSTILADRIN as a treatment option for adults with high-risk non-muscle invasive bladder cancer, highlighting its alternative approach to traditional chemotherapy and BCG.
Creative Information
| CID: | 7d5dda78-3dec-4a63-84df-f074a9432aab |
| CRID: | 25_gp5mdwk8 |
| Domain: | ferring.com |
| Seat: | TTD |
| Size: | 300x250 |
| Bid: | $0.44 |
| Timestamp: | 11/6/2025, 3:21:29 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/6/2025, 3:32:50 PM | 5.50s | |
| adomain_analysis | success | 11/6/2025, 3:47:36 PM | 4.55s | |
| adomain_capture | success | 11/6/2025, 3:47:32 PM | 0.22s | |
| ad_render | success | 11/6/2025, 3:32:44 PM | 29.44s | |
| brand_mapping | success | 11/6/2025, 3:21:29 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Ferring
Sensitive:Unverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 690.33 KB | ||||||||||||||||||||||
| Render Time: | 7.68 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 709.55 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


